Tumor Progression
mTOR Signaling and Cancer Progression
Liver Regeneration
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 16, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Shanbao Li1,2, Lei Li1, Junyi Wu1
1Department of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, People's Republic of China.
Tryptophan 2,3-dioxygenase (TDO) is overexpressed in liver cancer (HCC) and promotes tumor growth and spread. TDO may serve as a new biomarker for predicting patient outcomes in HCC.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: